FDA says do not “use” three more home COVID-19 tests because of the risk of “false results”
FDA says do not “use” three more home COVID-19 tests because of the risk of “false results”

FDA says do not “use” three more home COVID-19 tests because of the risk of “false results”

The U.S. Food and Drug Administration has issued warnings about three more at home COVID-19 test kits that it has not approved and may give false results.

The manufacturers of all three tests have also issued recalls.

The FDA issued warnings about these tests yesterday:

The FDA said consumers should not use the Celltrion DiaTrust COVID-19 Ag Rapid Test, which has been recalled.

These tests, the FDA said, “have not been approved, approved, or approved by the FDA for distribution or use in the United States. The FDA is concerned about the risk of false results using this unauthorized test.”

The FDA said that ACON Laboratories has withdrawn all Flowflex tests.

SD Biosensor has recalled its tests, and Celltrion USA has recalled the DiaTrust tests.

In February, the FDA had issued warnings about E25Bio COVID-19 Direct Antigen Rapid Test, Empowered Diagnostics CovClear COVID-19 Rapid Antigen Test and ImmunoPass COVID-19 Neutralizing Antibody Rapid Test for the same reasons.

Revoked COVID-19 home test kit

The FDA said consumers should not use the SD Biosensor Standard Q COVD-19 AG Home Test, which has been revoked.

Leave a Reply

Your email address will not be published.